SOD1 and chronic kidney disease: Studies on patients with stages 1 to 5 of CKD revealed that serum dimethylarginine (ADMA) and OS markers (erythrocyte SOD, GSH-Px, and plasma malondialdehyde (MDA)) were directly linked with different phases of CKD.